학술논문
NBI-921352, a first-in-class, NaV1.6 selective, sodium channel inhibitor that prevents seizures in Scn8a gain-of-function mice, and wild-type mice and rats
Document Type
Article
Author
Johnson, J.P.; Khakh, K.; Goodchild, S.J.; Chang, E.; Dean, R.; Feng, M.; Hussainkhel, A.; Li, J.; Lin, S.; Mezeyova, J.; Shuart, N.G.; Weeratunge, D.; Williams, A.; Xie, Z.; Yoo, R.; Young, C.; Focken, T.; Andrez, J.-C.; Bogucki, D.; Burford, K.; Chowdhury, S.; Decker, S.; Dehnhardt, C.; Gong, W.; Grimwood, M.; Hasan, A.; Jia, Q.; Lofstrand, V.; Sun, S.; Taron, M.; Wesolowski, S.; Wilson, M.; Zenova, A.; Zhang, W.; Tari, P.K.; Dube, C.; Bankar, G.; Nelkenbrecher, K.; Waldbrook, M.; De Boer, G.; Lee, S.; Lindgren, A.; Sojo, L.; Namdari, R.; Cutts, A.J.; Sherrington, R.P.; Pimstone, S.N.; Winquist, R.; Cohen, C.J.; Empfield, J.R.
Source
In: eLife . (eLife, March 2022, 11)
Subject
Language
English
ISSN
2050084X